StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
Shares of NASDAQ:BLPH opened at $0.04 on Thursday. The stock’s 50-day simple moving average is $0.04 and its two-hundred day simple moving average is $0.05. Bellerophon Therapeutics has a 52-week low of $0.03 and a 52-week high of $0.10.
Bellerophon Therapeutics Company Profile
Read More
- Five stocks we like better than Bellerophon Therapeutics
- How is Compound Interest Calculated?
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- 3 Ways To Invest In Coffee, Other Than Drinking It
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
